Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Europe
Asia & Oceania
Middle East & Africa
EMEA Thought Leadership
NHS Solutions
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn More
Insight & Feedback
Insight & Feedback (desc)
Costing Solutions
Costing Solutions (desc)
Clinical Coding Analytics
Clinical Coding Analytics (desc)
Benchmarking
Benchmarking (desc)
Analytics
Analytics (desc)
Pathway Transformation
Pathway Transformation (desc)
AppScript
AppScript (desc)
Securnet
Securnet (desc)
Life Sciences Industry
We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn More
Advancing UK Healthcare
We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
Pharmacy Communications
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn More
The IQVIA difference
Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Americas
Europe
Asia & Oceania
Middle East & Africa
EMEA Thought Leadership
White Paper
Improving Therapy Adherence Cost-Effectively with Measurable Impact
A UK Case Study in Diabetes
Dec 24, 2018
- Locations
- United Kingdom
- Improving Therapy Adherence Cost-Effectively with Measurable Impact
Get instant access
At a time when chronic, long-term conditions threaten to engulf the NHS, medicines optimisation is at the forefront of strategies to help stakeholders across the healthcare spectrum obtain the maximum value from investment in and use of medicines. Adherence to therapy is a critical enabler in this process, requiring multidisciplinary efforts to encourage better patient understanding and ownership of their treatment.
This new IQVIA white paper provides key recommendations for:
- Manufacturers to take a lead in implementing simple, scalable solution
- Health system processes to turn data and analytics into actionable insights and to monitor progress
- Options to significantly impact adherence, disease burden and patient outcomes